Comparable stake leader
Sumitomo Chemical Co., Ltd.
SEC ownership of Myovant Sciences Ltd.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001679082.
Disclosed value leader
Sumitomo Chemical Co., Ltd.
Comparable rows
0/2
Latest evidence
10 Mar 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Sumitomo Chemical Co., Ltd.
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
10 Mar 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001679082
- Issuer location
- London, United Kingdom
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Myovant Sciences Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sumitomo Chemical Co., Ltd.
Disclosed value leader
Sumitomo Chemical Co., Ltd.
Comparable rows
0/2
Latest evidence
10 Mar 2023
3/4/5
Highest disclosed value: $1,236,550,752
2 rows are not safely comparable across share classes.
Quick read
Sumitomo Chemical Co., Ltd. has the largest disclosed position value at $1.24B.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sumitomo Chemical Co., Ltd.'s linked filing trail.
Disclosed position value
Top 2
Sumitomo Chemical Co., Ltd.
$1.24B
Frank Karbe
$5.73M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sumitomo Chemical Co., Ltd. |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$1,236,550,752
45,798,177 shares
mixed-class rows
|
— | 10 Mar 2023 |
| Frank Karbe |
3/4/5
Principal Fin'l & Accounting
|
—
class O/S missing
|
$5,731,992
212,296 shares
|
— | 07 Jul 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 16 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to Myovant Sciences Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Largest Forms 3/4/5 holder
Sumitomo Chemical Co., Ltd.
Net 12M change
$0
Latest report
10 Mar 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Sumitomo Chemical Co., Ltd. | 10%+ Owner | $1,236,550,752 | Filing P/S | 10 Mar 2023 | ||
| Frank Karbe | Principal Fin'l & Accounting | $5,731,992 | Mixed | 07 Jul 2021 | ||
| David C. Marek | Principal Executive Officer, Director | Mixed | 10 Mar 2023 | |||
| Dr. Juan Camilo Arjona Ferreira | Chief Medical Officer | Mixed | 10 Mar 2023 | |||
| Matthew Lang | General Counsel & Corp. Secy. | Mixed | 10 Mar 2023 | |||
| Myrtle S. Potter | Director | Mixed | 10 Mar 2023 | |||
| Terrie Curran | Director | Mixed | 10 Mar 2023 | |||
| Uneek Mehra | Principal Financial Officer | Mixed | 10 Mar 2023 | |||
| Shigeyuki Nishinaka | Director | Mixed | 21 Oct 2022 | |||
| Mark Guinan | Director | Mixed | 10 Mar 2023 | |||
| Adele M. Gulfo | Director | Mixed | 10 Mar 2023 | |||
| Lauren Merendino | Chief Commercial Officer | Mixed | 10 Mar 2023 | |||
| Nancy Valente | Director | Mixed | 10 Mar 2023 |
Recent insider transactions for Myovant Sciences Ltd.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.